Status:
COMPLETED
Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
Beijing Hospital
Peking University Third Hospital
Conditions:
Intracranial Aneurysm
Eligibility:
All Genders
18-75 years
Brief Summary
In this study, 20 regional neurosurgery centers across the country will be included, and the study cohort will be constructed on the basis of the IARP-CP cohort.The artificial intelligence platform wa...
Eligibility Criteria
Inclusion
- 18-75 years old;
- At least one unruptured intracranial aneurysm was found by CTA;
- No relevant symptoms, receiving non-operative and conservative observation treatment;
- Signing the informed consent.
Exclusion
- Other cerebrovascular structural lesions (such as cerebrovascular malformation and arteriovenous fistula) or craniocerebral tumors;
- Fusiform or dissecting aneurysms;
- Traumatic, mycotic and atrial myxoma associated aneurysms;
- Suffering from systemic connective tissue diseases, such as polycystic kidney disease;
- Expectant survival of no more than 3 years due to other diseases or poor general conditions;
- Patients refuse to follow up or cannot communicate with them due to mental diseases;
- Pregnant women or participating in other aneurysm related studies.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04872842
Start Date
September 1 2021
End Date
May 1 2022
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China